Recurrent implantation failure can involve embryo, uterine, hormonal, or other biological factors, even when embryos appear to be good quality.
An embryo transfer can be one of the most hopeful stages of IVF. But sometimes, even after transferring good-quality embryos, pregnancy does not occur. When implantation fails repeatedly, doctors may consider recurrent implantation failure (RIF) and look for factors that could be affecting the embryo, uterus, or timing of implantation.
Recurrent implantation failure does not necessarily mean that pregnancy is impossible. It means that several unsuccessful transfers may justify a more detailed review of previous IVF cycles and potential causes.
The definition of RIF varies across studies. The 2026 American Society for Reproductive Medicine (ASRM) guidance defines RIF based on failure to achieve the expected cumulative chance of a positive pregnancy test after transferring an estimated number of good-quality blastocysts.
What Is Recurrent Implantation Failure?
Recurrent implantation failure refers to repeated failure of an embryo to implant following embryo transfer during IVF.
Implantation is a complex process. The embryo must develop appropriately, reach the blastocyst stage, interact with the uterine lining, and attach and invade the endometrium at the right time.
There is no single universally accepted definition of RIF. Current guidance emphasizes considering factors such as embryo quality, embryo chromosome status, age, and the number of previous transfers rather than relying only on a fixed number of failed IVF cycles.
Why Does a Good Embryo Not Implant?
A good-looking embryo under the microscope is not necessarily a chromosomally normal embryo. Embryo morphology provides useful information, but it cannot identify every genetic or developmental problem.
Some important embryo not implanting causes include:
1. Embryo Chromosomal Abnormalities
Chromosomal abnormalities, or aneuploidy, are considered an important cause of implantation failure. The likelihood of aneuploidy generally increases with maternal age.
An embryo can have an excellent appearance but still contain an abnormal number of chromosomes. Such an embryo may have limited potential for implantation or continued development.
2. Problems With the Uterine Cavity
The uterus needs to provide a suitable environment for implantation. Polyps, fibroids that distort the cavity, adhesions, a uterine septum, or other structural abnormalities may affect implantation.
Doctors may use tests such as sonohysterography, hysteroscopy, or three-dimensional ultrasound to assess the uterine cavity when RIF is suspected.
3. Hydrosalpinx
A hydrosalpinx is a fluid-filled fallopian tube. Although the embryo is transferred directly into the uterus during IVF, a hydrosalpinx can still be relevant to implantation and may need evaluation as part of an infertility assessment.
4. Endometrial or Inflammatory Conditions
Conditions affecting the endometrium may also be investigated. For example, chronic endometritis has been studied in people with recurrent implantation failure.
However, testing and treatment should be based on clinical circumstances because evidence for some proposed causes and treatments remains limited.
5. Hormonal and Progesterone Factors
Progesterone plays an important role in preparing and maintaining the endometrium for implantation.
In frozen embryo transfer cycles, the timing and type of progesterone support may therefore be reviewed by the fertility specialist. However, ASRM notes that there is currently insufficient evidence to recommend one specific progesterone supplementation protocol for people with RIF.
Does Embryo Quality Guarantee Implantation?
No.
Embryo grading mainly describes characteristics such as cell organization and development. It does not provide a complete picture of the embryo’s chromosome status or its ability to implant.
This is why repeated implantation failure may require looking beyond embryo appearance alone.
For patients with untested embryos, PGT-A may sometimes be discussed as part of shared decision-making to investigate whether embryo aneuploidy contributes to repeated implantation failure. However, ASRM states that there is currently no evidence that PGT-A increases live birth rates specifically in patients with RIF.
What Is an ERA Test in IVF?
The ERA test in IVF, or endometrial receptivity analysis, is designed to evaluate the molecular characteristics of the endometrium.
The test analyzes gene expression in an endometrial sample and attempts to classify the lining as receptive or nonreceptive. The idea is that the result could potentially help determine the timing of embryo transfer.
This approach is based on the concept of the “window of implantation”, a period during which the endometrium may be particularly prepared to receive an embryo.
However, ERA should not be viewed as a guaranteed explanation for implantation failure.
What Does Endometrial Receptivity Testing Tell You?
Endometrial receptivity testing attempts to determine whether the uterine lining has a molecular profile associated with receptivity at a particular point in the menstrual or hormone-prepared cycle.
The theory is straightforward:
Endometrial preparation → receptivity assessment → adjusted transfer timing, if indicated
But the clinical evidence is more complicated.
ASRM’s 2026 committee opinion reports conflicting evidence regarding ERA in RIF. A large randomized trial found that using ERA to guide the timing of transfer of euploid embryos did not significantly improve live birth rates compared with standard timing. ASRM therefore states that there is insufficient evidence to support routine ERA testing in patients with RIF.
What Tests May Be Considered After Repeated Failed Transfers?
A fertility specialist may review several areas rather than ordering every available test.
Depending on the individual situation, evaluation may include:
- Review of previous IVF cycles and embryo development
- Assessment of the uterine cavity
- Sonohysterography or three-dimensional ultrasound
- Hysteroscopy when appropriate
- Evaluation for conditions such as hydrosalpinx
- Review of embryo chromosome status
- Consideration of parental karyotyping in selected cases
- Assessment for chronic endometritis when clinically appropriate
- Review of hormone preparation and progesterone support
ASRM recommends a detailed review of the patient’s history and previous IVF cycles before deciding which investigations are appropriate. It also notes that extensive testing is unnecessary when no clear, correctable cause is identified.
Tests That Are Not Routinely Recommended
Repeated IVF failure can understandably lead patients to search for every possible test. However, more testing does not automatically mean better treatment.
ASRM currently does not recommend routine use of several proposed investigations or treatments for RIF because evidence that they improve live birth outcomes is insufficient. These include endometrial receptivity panels, BCL-6 testing, endometrial scratching, sperm DNA fragmentation testing specifically for RIF, and several immune-based interventions.
This is why treatment decisions should be individualized rather than based on a long checklist of commercially available tests.
What Happens After Recurrent Implantation Failure?
The next step is usually a structured review rather than immediately repeating the same IVF protocol.
A fertility specialist may look at:
Step 1: Review previous transfers
Examine embryo stage, grading, number of embryos transferred, development, and previous cycle details.
Step 2: Review embryo factors
Consider age-related aneuploidy and whether genetic testing was performed.
Step 3: Check the uterus
Look for polyps, adhesions, fibroids, congenital abnormalities, hydrosalpinx, or other structural issues.
Step 4: Review the transfer cycle
Evaluate endometrial development, hormone preparation, progesterone support, and embryo transfer details.
Step 5: Consider targeted testing
Only tests that could reasonably change management should generally be considered.
Step 6: Discuss the next transfer
If no correctable cause is identified, another embryo transfer may still be appropriate.
ASRM notes that many patients ultimately achieve pregnancy after additional embryo transfers when no clear correctable cause is found.
Is Recurrent Implantation Failure Treatable?
There is no single treatment for RIF because implantation failure can have different causes.
If a uterine abnormality is identified, treating that problem may be considered. If embryo chromosome abnormalities are suspected, the fertility team may discuss embryo testing or other reproductive options.
In other cases, no clear cause may be found.
That can be frustrating, but unexplained RIF does not mean that future embryo transfers cannot succeed. The evidence supports an individualized approach rather than automatically adding multiple tests or treatments.
Frequently Asked Questions
How many failed IVF transfers are considered recurrent implantation failure?
There is no single universal number. Current ASRM guidance defines RIF using the expected cumulative probability of implantation rather than simply counting failed cycles. Current literature often discusses approximately 3 to 6 failed euploid embryo transfers, while the number can differ when embryos have not undergone genetic testing.
Can a euploid embryo fail to implant?
Yes. A euploid embryo has the expected chromosome number, but euploid status does not guarantee implantation or live birth. Other embryo, uterine, hormonal, and biological factors can influence the outcome.
Is ERA test IVF treatment proven to improve success?
Current evidence does not establish routine ERA testing as a way to improve live birth outcomes in RIF. ASRM states that there is insufficient evidence to support routine ERA testing in RIF patients.
What is the most common cause of implantation failure?
Embryo chromosomal abnormalities are considered an important contributor to implantation failure, particularly because aneuploidy becomes more common with increasing maternal age. However, repeated implantation failure can involve multiple factors, so one cause should not automatically be assumed for every patient.
Should I repeat IVF after recurrent implantation failure?
The decision depends on individual circumstances, including embryo status, age, uterine findings, previous treatment, and whether a correctable cause has been identified. A fertility specialist can review the previous cycles and determine whether another transfer or additional evaluation is appropriate.
Key Takeaway
Recurrent implantation failure can happen even when embryos appear to be good quality. Embryo chromosome abnormalities, uterine conditions, hydrosalpinx, endometrial factors, and other biological factors may contribute to unsuccessful implantation.
An ERA test in IVF and other forms of endometrial receptivity testing may sound like an obvious next step, but current evidence does not support using ERA routinely for RIF. A targeted evaluation based on previous IVF cycles and individual clinical factors is generally more useful than automatically ordering every available test.
If you have experienced repeated failed embryo transfers, discuss your individual history and treatment options with a qualified fertility specialist. This article is for educational purposes and does not replace personalized medical advice.
